RATIONALE:
The regulatory, epigenomic, and transcriptomic features of the human brain have not been comprehensively compiled across time, regions, or cell types. Understanding the etiology of neuropsychiatric disorders requires knowledge not just of endpoint differences between healthy and diseased brains but also of the developmental and cellular contexts in which these differences arise. Moreover, an emerging body of research indicates that many aspects of the development and physiology of the human brain are not well recapitulated in model organisms, and therefore it is necessary that neuropsychiatric disorders be understood in the broader context of the developing and adult human brain.
RESULTS:
Here we describe the generation and analysis of a variety of genomic data modalities at the tissue and single-cell levels, including transcriptome, DNA methylation, and histone modifications across multiple brain regions ranging in age from embryonic development through adulthood. We observed a widespread transcriptomic transition beginning during late fetal development and consisting of sharply decreased regional differences. This reduction coincided with increases in the transcriptional signatures of mature neurons and the expression of genes associated with dendrite development, synapse development, and neuronal activity, all of which were temporally synchronous across neocortical areas, as well as myelination and oligodendrocytes, which were asynchronous. Moreover, genes including MEF2C, SATB2, and TCF4, with genetic associations to multiple brain-related traits and disorders, converged in a small number of modules exhibiting spatial or spatiotemporal specificity.
CONCLUSION:
We generated and applied our dataset to document transcriptomic and epigenetic changes across human development and then related those changes to major neuropsychiatric disorders. These data allowed us to identify genes, cell types, gene coexpression modules, and spatiotemporal loci where disease risk might converge, demonstrating the utility of the dataset and providing new insights into human development and disease.
T he development of the human central nervous system is an intricate process that unfolds over several decades, during which time numerous distinct cell types are generated and assembled into functionally distinct circuits and regions (1) (2) (3) (4) . These basic components of the brain are neither born mature nor static throughout their lifetimes; over the course of development, they undergo a variety of molecular and morphological changes. As a consequence, the characteristics of a given cell, circuit, or brain region described at a given time offer only a snapshot of that unit.
The processes guiding the development of the nervous system are reliant on the diversity and precise spatiotemporal regulation of the transcriptome (1) (2) (3) (4) . There is increasingly persuasive evidence that dysregulation of the transcriptional, regulatory, and epigenetic processes underlying the spatial architecture and temporal progression of human neurodevelopment can have dire consequences for brain function or strongly affect the risk of neuropsychiatric disorders (5) (6) (7) . Indeed, many of the regulatory and epigenomic features governing the transcriptome of the developing human nervous system may be specific to particular developmental contexts in humans or closely related primate species. As such, it is difficult to identify or fully study human functional genomic elements using most common model organisms or cell culture systems (8) . Assaying human cells and postmortem tissues solves some of these problems, but challenges, including the availability and quality of developmental tissue, limit the scale of such analyses. Consequently, despite ongoing efforts, our understanding of different facets of the transcriptional, regulatory, and epigenetic architecture of the human nervous system, particularly during early developmental periods, remains highly incomplete (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) .
To begin rectifying this deficiency, the National Institutes of Health-funded PsychENCODE (http://psychencode.org) and BrainSpan Consortia (www.brainspan.org) sought to generate and analyze multidimensional genomics data from the developing and adult human brain in healthy and disease states.
Study design and data generation
Here we describe the generation and integrated analysis of multiple genomic data modalities, including transcriptomic profile, DNA methylation status, histone modifications, CTCF binding sites, and genotype generated from bulk tissue (1230 samples from 48 brains) or at the singlecell or single-nucleus level (18,288 cells or nuclei from 12 brains) from 60 de-identified postmortem brains obtained from clinically and histopathologically unremarkable donors of both sexes and multiple ancestries. Subject ages ranged from 5 postconceptional weeks (PCW) to 64 postnatal years (PY) ( Fig. 1 and tables S1 to S6). Genotyping of DNA extracted from brain with a HumanOmni2.5-8 BeadChip confirmed subject ancestry and revealed no obvious genomic abnormalities (22).
For transcriptome analysis, tissue-level mRNA sequencing (mRNA-seq) was performed on a total of 607 histologically verified, high-quality tissue samples from 16 anatomical brain regions [11 areas of the neocortex (NCX), hippocampus (HIP), amygdala (AMY), striatum (STR), mediodorsal nucleus of thalamus (MD), and cerebellar cortex (CBC)] involved in higher-order cognition and behavior [ Fig. 2A, (22) ]. These regions were systematically dissected from 41 brains ranging in age from 8 PCW to 40 PY [18 females and 23 males; postmortem interval (PMI) = 12.9 ± 10.4 hours; tissue pH = 6.5 ± 0.3; RNA integrity number = 8.8 ± 1] ( Fig. 1 and table S1 ). Because of the limited amounts of prenatal samples, small-RNA sequencing (smRNA-seq) was performed on 16 regions of 22 postnatal brains, with 278 samples passing quality control measures ( Fig. 1 and table S2). These tissue-level RNA-seq analyses were complemented by single-cell RNA sequencing (scRNA-seq) data generated from 1195 cells collected from embryonic fronto-parietal neocortical wall and mid-fetal fronto-parietal neocortical plate and adjacent subplate zone of an independent set of nine brains ranging in age from 5 to 20 PCW ( Fig. 1 and table S3 ) and single-nuclei RNA sequencing data (snRNA-seq) generated from 17,093 nuclei from the dorsolateral prefrontal cortex (DFC, also termed DLPFC) of three adult brains ( Fig. 1 and table S4 ). For epigenome analyses, DNA cytosine methylation was profiled with the Infinium HumanMethylation450 BeadChip in 269 postnatal samples covering the same 16 brain regions analyzed by RNA-seq ( Fig. 1 and table S5 ). Additional epigenomic data was generated with chromatin immunoprecipitation sequencing (ChIP-seq) for histone marks H3K4me3 (trimethylated histone H3 lysine 4), H3K27me3 (trimethylated histone H3 lysine 27), and H3K27ac (acetylated histone H3 lysine 27) and the epigenetic regulatory protein CTCF, which together identify a large fraction of promoters, repressors, active enhancers, and insulators. These data were generated from DFC and CBC of a subset of samples from mid-fetal, infant, and adult brains ( Fig. 1 and table S6 ). Stringent quality control measures (figs. S1 to S8) were applied to all datasets before in-depth analyses. We also validated some results by applying independent approaches (figs. S9, S10, and S18). Finally, to enable more powerful comparisons, we grouped specimens into nine time windows (W1 to W9) on the basis of major neurodevelopmental milestones and unsupervised transcriptomebased temporal arrangement of constituent specimens ( Fig. 1A and tables S1 to S6).
Global spatiotemporal dynamics
We found that most protein-coding genes were temporally (67.8%) or spatially (54.5%) differentially expressed (22) between at least two time windows or regions, respectively, with the majority of spatially differentially expressed genes (95.8%) also temporally differentially expressed. To gain a broad understanding of this transcriptomic variation, we analyzed the level of similarity between individual samples in the mRNA-seq dataset using multidimensional scaling applied to both gene and isoform transcriptlevel analyses (Fig. 2B and figs. S11 and S12). In both analyses, we found a clear divide between samples from embryonic through late mid-fetal development (W1 to W4) and samples from late infancy through adulthood (W6 to W9), with samples from the late fetal period through early infancy (W5) generally spanning this divide. To determine the relationship between these three groups, we performed unsupervised hierarchical clustering analysis and found that all samples from W5, including the late fetal samples, were more similar to early postnatal samples than to late mid-fetal samples ( fig. S13 ). Analysis of largescale, intraregional changes in the transcriptome across time also suggest a major transition that begins before birth. The transcriptomes of major brain regions and neocortical areas correlated well across both embryonic and early to midfetal (W1 to W4) and later postnatal (W6 to W9) development but displayed a sharp decrease in correlation across late fetal development and early infancy (W5) (Fig. 2C and fig. S14 ). This transition was also apparent at the interregional level. Pairwise comparisons of gene expression across all 16 brain regions found a reduction in the number of genes showing differential regional expression during W5 relative to all other windows ( fig. S15 ). Taken together, our observation of high variation during embryonic and early to mid-fetal ages followed by a decrease across late fetal ages and the subsequent resumption of higher levels of inter-and intraregional variation during late childhood and adolescence revealed a cup-shaped, or hourglass-like, pattern of transcriptomic development (Fig. 2D) .
To further explore how regional transcriptomic profiles change with age, we applied the adjustment for confounding principal components analysis algorithm (AC-PCA) (23) , which adjusts for interindividual variations. Within any given developmental window, AC-PCA exhibited a clear separation of brain regions, but the average dissimilarity between transcription profiles of brain regions declined from W1 to W5 and then increased with age after W5 (Fig. 2, E and F, and fig.  S16 ). Implying a relationship between transcriptional signatures and developmental origin, we found that dorsal pallium-derived structures of the cerebrum (i.e., NCX, HIP, and AMY) as well as STR became increasingly similar across prenatal development, whereas CBC and MD remained most distinct across all time windows. To confirm these observations and to evaluate the contribution of each brain region to the regional variation described by AC-PCA, we quantified the mean distance in the first two principal components across brain regions, excluding from the AC-PCA one region at a time. Because of the relative transcriptomic uniqueness of the CBC, its exclusion unmasked a qualitatively distinct and pronounced cup-shaped pattern with a transition beginning before birth and spanning the late fetal period and early infancy (Fig. 2F) . CBC was again the most distinct region of the brain after multidimensional scaling analysis for expressed mature microRNAs (miRNAs), a small RNA species enriched within our smRNA-seq dataset, and the dominant contributor to miRNA expression variance ( fig. S17 ).
The global late fetal transition and overall cupshaped developmental dynamics we observed were also apparent when this analysis was repeated for the 11 neocortical areas included in this study (Fig. 3A and fig. S16 ). We observed greater dissimilarity across areas at early fetal ages (Fig. 3A) , with prefrontal areas [medial prefrontal cortex (MFC), orbital prefrontal cortex (OFC), DFC, and ventrolateral prefrontal cortex (VFC)] being the most distinct. In addition, reflecting the spatial and functional topography of the NCX, both rostro-caudal and dorsal-ventral axes were evident in the transcriptome during fetal development. Areal differences were also seen at later ages, with functional considerations likely taking precedence over topographical arrangements. For example, VFC clustered closely with primary motor (M1C) and somatosensory (S1C) cortex, likely reflecting functional relationships with orofacial regions of the motor and somatosensory perisylvian cortex ( fig. S16 ). Across the entirety of human brain development, transcriptomic variation between cortical regions also showed a pronounced decrease centered on the late fetal and early infancy samples of W5 (i.e., perinatal window), again reminiscent of a cupshaped pattern (Fig. 3, A and B, and fig. S16 ). Similar to gene expression, global measures of alternative splicing, such as the ratio between reads including or excluding exons [i.e., the percent spliced in index (PSI)], were higher during prenatal than postnatal ages (fig. S18 and table S7). So too was the gene expression of 68 RNAbinding proteins selected because of their involvement in RNA splicing and their analysis in adulthood by the Genotype-Tissue Expression (GTEx) project (24) . Hierarchical clustering of expression data for these proteins also revealed a late fetal transition (fig. S19). Coincident with these observations, we found that genes exhibiting the highest interregional variation in expression in any given window [see (22)] exhibited a higher PSI during that window than iteratively chosen control groups of genes (fig. S18). Taken together, these analyses suggest that broad phenomena in the developing human brain, including a late fetal transition in intra-and interregional transcriptomic variation, may be amplified by alternative splicing.
Cellular heterogeneity and developmental dynamics
The high interareal variation observed during embryonic and early to mid-fetal development ( Fig. 3B ) coincides with a crucial period in neural development and the suspected etiology of psychiatric diseases (4) . To help understand the temporal dynamics underlying this variation in gene expression, we analyzed our scRNA-seq data from embryonic fronto-parietal neocortical wall and mid-fetal fronto-parietal neocortical plate and adjacent subplate zone alongside our snRNA-seq data from adult human NCX and other independent datasets from overlapping developmental time points (12, 25, 26) . To do so, we first applied a clustering and classification algorithm (27, 28) to the prenatal scRNAseq data after an initial division of the dataset on the basis of the age of the donor brain (i.e., embryonic or fetal), obtaining 24 transcriptomically distinct cell clusters ( fig. S20 ). Reflecting the rapid developmental change occurring across embryonic and fetal development and the relative homogeneity of cell-type composition as compared to adult ages, as well as the specific distribution of samples in our dataset, a number of these clusters were comprised of cells from only a single donor brain, and vice versa. Suggesting that this resulted from spatiotemporal changes across brain development rather than artifactual changes related to data processing, we confirmed broad classifications of individual cells and general relationships between cell clusters and donor brains using an alternative clustering algorithm ( fig. S21 ). Differential expression analysis and measurements of expression specificity recovered well-known gene markers of distinct types of neuronal and non-neuronal progenitor and postmitotic cell types (figs. S20 and S22 and table S8), as well as closely related groups of cell types (i.e., markers enriched in all prenatal excitatory neuron clusters) ( fig. S22 ).
We complemented these data with snRNA-seq from adult human DFC ( fig. S20) immunohistochemistry on independent specimens confirmed the robust coexpression of these genes in L1 of the prenatal cortex, but not in L1 or in other cortical layers of the adult cortex ( fig. S26 ). These data imply that the molecular identities of many neuronal cell types are not fully resolved before the end of mid-fetal development and are likely malleable during early postmitotic differentiation. Next, we utilized our single-cell and singlenucleus datasets to deconvolve bulk tissue mRNAseq samples and estimate temporal changes in the relative proportions of major cell types in the NCX. The combined analysis revealed the cellular architecture of distinct neocortical areas and their variations across development. We observed temporal changes in cellular composition and maturational states, including the most dramatic changes during a late fetal transition (Fig. 3, C to E) . For example, transcriptomic signatures for fetal excitatory neurons and fetal interneurons were generally inversely correlated with progenitor cell signatures during embryonic and early fetal development, but fetal neuron signatures nonetheless decreased across midfetal to late fetal development despite a concomitant reduction in the progenitor cell signature, an observation that was likely affected by our dissection strategy [ Fig. 3C, (22) ]. Similarly, signatures for adult excitatory neurons increased rapidly across the late fetal period and early infancy, coincident with the decrease in signatures of fetal excitatory neurons and interneurons (Fig. 3C ). As expected, the molecular signatures for early born, deep-layer excitatory neurons preceded those for late born, upper-layer excitatory neurons ( fig. S27 ). Transcriptomic signatures for prenatal oligodendrocytes and prenatal astrocytes also began to emerge during mid-fetal periods and increased rapidly across the late fetal transition and early infancy (Fig. 3C) . Demonstrating the robustness of these observations, independent deconvolution using two alternate fetal single-cell datasets (12, 26) yielded similar results (figs. S27 and S30).
Given the increase in adult cell-type signatures during W5, we next reasoned that the observed decrease in interregional transcriptomic divergence during late fetal periods and infancy may reflect a synchronized transition from fetal to more mature features of neural cells. Consequently, we analyzed the variance in cell typespecific signatures across neocortical areas, which varies in accordance with their relative proportion, and found that the maximum cell type interareal variation through time recapitulated the developmental cup-shaped pattern (Fig. 3D) , with large variation in the proportion of neural progenitor cells and fetal excitatory neurons (figs. S28 and S29). Beginning during early postnatal periods, we observed increased proportions and variance in the signatures of astrocytes and, by adulthood, mature excitatory neurons (Fig.  3E) . These observed temporal differences in the magnitudes and variances of the relative proportions of certain cell types and the global heterogeneity of the cell type composition at each window at least partially explain the observed pattern of interareal differences across development. Gene Ontology (GO) enrichment analysis using the top variant genes in each window, with all genes expressed in each window as background, provided further support for these changes in cell composition across areas and time. Commensurate with the changes we observed in discrete cell populations, biological processes-including neurogenesis in early developmental windows (W1 to W4), myelination in the perinatal window (W5), and sensory and ion activity calcium-related biological processes in later postnatal windows (W7 to W9), among others-exhibited regional variation in the global brain transcriptome ( fig.  S31 and table S9 ). Similar patterns of interregional variation involving discrete cell types were also observed in the macaque neocortical transcriptome (34) , indicating that these are conserved and consistent features of prenatal primate NCX.
Other lines of evidence also suggested pronounced and qualitatively distinct regional differences in myelination, synaptic function, and neuronal activity. For example, although we observed differences in the expression of genes associated with these processes (10) across the NCX ( fig. S31 and table S9 ), TempShift, a Gaussianbased model that allows the quantification of temporal shifts in the trajectories of groups of genes represented by their first principal components (34) , indicated that of these processes, only genes associated with myelination displayed such a shift (Fig. 4A) . Conversely, perhaps reflecting functional or areal diversity in cell subtypes, we observed no similar temporal shift in the expression of genes associated with synaptogenesis or neuronal activity, confirming these results through reference to published posttranslational analyses of myelinated fiber density (35) and synaptic density (36) conducted across multiple neocortical areas (Fig. 4B) . Crucially, although genes associated with these processes were expressed across the late fetal transition (Fig. 4C) , of the processes analyzed, only myelination contributed to the increased interareal differences we observed during this period (Fig. 4D) . Suggesting that these differences are a conserved feature of primate development, we also observed similar areal differences in the transcriptional signatures of oligodendrocytes in the macaque NCX.
Overall, these observations indicate that higher levels of divergence during early prenatal and later postnatal development reflect regional variations in cell type composition, likely arising from topographical variation in progenitor populations and neuron development during prenatal ages and cell type and functional diversification during later postnatal ages.
Spatiotemporal and multimodal integration
We next sought to assess temporal variation in epigenetic signatures and their relationships to gene expression, development, and biological processes. Global DNA methylation profiling revealed that most CpG loci were either hypermethylated [37.5%; beta value (b) fig. S32) , but only about 10% of the tested methylation sites were progressively hyperor hypomethylated through prenatal windows, postnatal windows, or both. Similarly, most methylation sites also exhibited regional variation, with 64% of tested sites differentially methylated between at least two brain regions at postnatal ages. Additionally, 16% of tested sites were differentially methylated between at least two neocortical areas. Conversely, most putative promoters (66%) and a substantial proportion of were regionally (15%), temporally (17%), or spatiotemporally (24%) enriched than putative promoters (8, 14 , and 12%, respectively). These differences, which suggest a greater role for enhancers relative to promoters in contributing to differential spatiotemporal gene expression,
were selectively validated using quantitative droplet digital polymerase chain reaction (ddPCR) ( fig. S10 ). We next explored correlations between methylation, histone modifications, and gene expression (figs. S32 to S34). In the adult, we found that TSSs that were more highly methylated were associated with genes that were expressed at low levels at the corresponding age, and vice versa. These relationships were not strongly indicated for methylation at other locations in the gene body ( fig. S32) Progressively hyper-methylated postnatally T S S A ll e n h a n c e r s F e t a l e n h a n c e r s A d u lt e n h a n c e r s Progressively hypo-methylated postnatally N e u r o n a l G li a l were generally enriched for sites where methylation progressively increased across postnatal ages and associated with genes whose expression was higher during fetal development than adulthood and whose expression was enriched in neurons as compared to glia. Conversely, adult-active enhancers were enriched for sites exhibiting progressively lower methylation across postnatal ages and depleted for associations with higher fetal gene expression and expression in neurons. These enhancers were also enriched for gene ontology terms generally involving neurons and glia, respectively. OR, odds ratio. (B) Sites where methylation progressively increased across postnatal ages and where methylation progressively decreased across postnatal ages were generally enriched for fetal enhancers and genes whose expression was enriched in neurons, or adult enhancers and genes whose expression was enriched in glia, respectively, as well as related gene the adult human brain also correlated strongly with increased gene expression in CBC relative to DFC ( fig. S33) , and vice versa. Similarly, putative fetal-active and adult-active enhancers were associated with higher fetal or adult gene expression, respectively. In addition to epigenetic effects on gene expression, we observed discrete relationships between specific enhancers, methylation sites, and cell type-specific signatures. For example, enhancers identified during the fetal period were enriched for methylation sites that were progressively more methylated across postnatal ages (post-up), whereas adult-active enhancers were enriched for methylation sites that were progressively less methylated across postnatal ages (post-down) (P < 0.05, Fisher's exact test) [ Fig. 5A and fig. S35, (22) ]. Both post-up and post-down sites were themselves depleted at TSSs and enriched for sites undermethylated in neurons [neuron undermethylated (NUM) sites] and undermethylated in non-neurons (non-NUM sites) ( fig. S35 ). They were also enriched for fetal and adult enhancers, respectively (Fig.  5B) . Post-up sites were also enriched in both neuron-and glia-enriched-genes, whereas postdown sites were enriched only in glial genes (Fig. 5B) (P < 0.05, Fisher's exact test). Further suggesting a relationship between enhancer activity, methylation, and cell type, genes associated with fetal-active enhancers, as well as those associated with differentially methylated regions (DMRs) composed of post-up sites (22), were enriched for GO terms related to early events in neural development-such as neurogenesis, cell differentiation, and synaptic transmission-but generally not for processes occurring later in development (Fig. 5B and fig. S35 ). By contrast, genes near adult-active enhancers and postdown DMRs exhibited enrichment for postnatal or adult processes including myelination and axon ensheathment (P < 0.01, Fisher's exact test) (Fig. 5B and fig. S35 ). Taken together, these data demonstrate relationships between gene expression and epigenetic modifications, including methylation status and putative regulatory elements, as well as signatures of specific cell types and developmental programs.
We next sought further evidence that cellular dynamics contributed to the late fetal transition through the analysis of cell type-and spatiotemporal-specific patterns of gene expression and epigenetic regulation. We curated 73 gene coexpression modules resulting from weighted gene correlation network analysis (WGCNA) according to spatial relationships between brain regions and the temporal relationships of gene expression in the NCX across the late fetal transition ( fig. S36 and tables S10 and S11). We found 44 modules that showed expression differences among regions in the brain (spatial), 40 modules that showed expression differences between prenatal and postnatal neocortical areas (temporal), 16 modules that were neither spatially nor temporally dynamic, and 27 modules that exhibited both spatial and temporal differences (Fig. 5C) . A significantly greater than expected number of these spatiotemporally dynamic modules (including modules 2, 10, 32, and 37) exhibited their greatest change in neocortical expression from W2 through W5 (P < 0.0118, hypergeometric test) (Fig. 5C,  fig. S37 , and table S12). Genes whose expression was enriched in excitatory neurons, genes associated with putative fetal-active enhancers, and/or genes associated with NUM sites-a selection of characteristics we refer to collectively as neuronal (N)-type associations-were also enriched in spatiotemporal dynamic modules (P < 0.0029, hypergeometric test) (Fig. 5C, fig. S37 , and table S12). Conversely, genes associated with adultactive enhancers, methylation sites hypomethylated in non-NUM sites, and glial genes [glial (G)-type modules or associations in Fig. 5C , fig. S37 and table S12] were enriched among the 13 modules where temporal (P < 0.0002, hypergeometric test), but not spatial, specificity was observed. These observations indicate increased spatial diversity of neuronal cell types relative to glial cell populations.
Analyses by sex revealed that modules enriched for the 783 genes exhibiting sex-differential expression (sex-DEX) in at least two consecutive windows in at least one brain region were enriched among modules with no spatial or temporal differential expression in the NCX (P < 0.0029, hypergeometric test) and depleted among spatiotemporal modules (P < 0.0021, hypergeometric test) (Fig. 5C and fig. S37 ). There were four modules exhibiting temporal expression differences in the NCX that were also enriched for sex-biased genes, as well as glial and other cell type-enriched markers, but these did not represent a significant enrichment in sex-DEX enriched modules among strictly temporal modules (P < 0.132, hypergeometric test). In addition, no module comprised of autosomal genes exhibited persistent male or female dimorphism across both prenatal development and later postnatal ages such as adolescence or adulthood (figs. S38 and S39); in cases in which an autosomal module was sex-DEX throughout development, the sex exhibiting higher expression reversed between early and late postnatal development ( fig. S39 ). This observation was upheld when multiple thresholds were used for the identification of sexual dimorphism ( fig. S40) . Similarly, we identified no autosomal genes that exhibited sexual dimorphism throughout development in all brain regions or neocortical areas (figs. S38 and S39). association studies (GWAS) and are enriched in putative noncoding regulatory elements (29) (30) (31) . We sought to determine whether the proportion of phenotypic variance explained by common single-nucleotide polymorphisms (SNPs) in large neuropsychiatric GWAS (i.e., SNP heritability) was enriched in the cis-regulatory elements we identified at W1, W4, W5, and W9 in DFC and CBC. Toward this end, we collected GWAS data concerning neuropsychiatric disorders or personality traits including schizophrenia (SCZ) from CLOZUK (37), Alzheimer's disease (AD) from IGAP (38), Parkinson's disease (PD) (39), autism spectrum disorder (ASD) (40) , attention deficit hyperactivity disorder (ADHD) from iPSYCH (41), major depressive disorder (MDD) (42), bipolar disorder (BD) (43), intelligence quotient (IQ) (44) , and neuroticism (45), as well as non-neural traits such as height from GIANT (46), inflammatory bowel disease (IBD) (47), total cholesterol levels (48) , and an endophenotype associated with diabetes (HBA1C) (49) . Using partitioned linkage disequilibrium (LD) score regression analysis, we found that SNP heritability in SCZ, IQ, and neuroticism were exclusively enriched in DFC-specific, but not CBC-specific, regulatory elements as identified by peak regions of H3K27ac activity. By contrast, SNP heritability in AD or PD rendered no significant associations, and the analysis on ASD, ADHD, BD, and MDD was only nominally enriched or not enriched in putative regionspecific fetal enhancers [ Fig. 6 and fig. S41 , (22)]. Non-neural traits (such as height and HBA1C) were also not enriched in either DFC-or CBCspecific regulatory elements but were instead enriched in regulatory elements active in the two brain regions ( fig. S41 ), indicating a general enrichment of many of our tested GWASs in H3K27ac regions when considering a set of more ubiquitous regulatory regions. After aggregating GWAS SNPs and identifying candidate associated regions on the basis of their P values and LD patterns in individuals of northwest European ancestry (50), we next leveraged partially overlapping Hi-C datasets, derived from mid-fetal and adult NCX and processed by two independent research groups (51-53), as well as H3K27ac activity in the brain, to develop two lists of genes putatively associated with those GWAS-associated regions. To do so, we initially populated both lists of diseaseassociated genes by identifying TSSs overlapping H3K27ac peaks that themselves overlapped a GWAS significant region, as well as genes directly affected by GWAS significant variants within the LD region, as predicted by EnsemblV78. We next expanded these lists of disease-associated genes by identifying TSSs that interact with H3K27ac peaks overlapping GWAS significant regions, excluding interactions that did not overlap with at least one H3K27ac peak at each end or where peak-to-peak interactions were not concordant in time and brain region. In the first, less stringent list (list 1), a single interaction from either of the two Hi-C datasets was sufficient to associate a gene to a GWAS locus (table S13) . For the second, more stringent list (list 2), we excluded those genes whose only association to a GWAS locus was via Hi-C interactions identified in only one of the two Hi-C datasets (table S14) .
We next sought to determine the cell types enriched for the expression of the high-stringency genes implicated in neuropsychiatric disorders or brain-based traits, using our prenatal scRNAseq and adult snRNA-seq datasets and matching prenatal and adult datasets generated from the macaque (34) . We found numerous cell types enriched for disease-associated loci in both human and macaque ( fig. S42 ). For example, neocortical excitatory neurons were enriched for the expression of genes we associated with IQ in both the fetal and adult human as well as the fetal and adult macaque. However, we found no other excitatory neuron populations in the macaque AMY, STR, HIP, thalamus, or cerebellum enriched for genes associated with IQ. Similarly, neural progenitors in the prenatal macaque AMY, but not progenitors in the prenatal macaque HIP, thalamus, NCX, or STR, were enriched for the expression of genes associated with MDD, a finding especially intriguing given the variable or potentially increased size of some amygdalar nuclei in MDD patients (54, 55) . Similarly confirmatory was the enrichment of SCZ risk genes in cortical excitatory neurons (56) , with enrichment also observed in embryonic and/or fetal progenitor cells and adult cortical interneurons.
Analysis of gene coexpression modules found that genes in the more-stringent early-onset disease (ADHD, SCZ, and MDD) risk lists converged on 7 of 73 coexpression modules, whereas adult-onset disease (AD and PD) risk-gene lists converged on five partially overlapping modules ( fig. S37 and table S12 ). Eight of these 10 total disease-associated modules (Fig. 7A) exhibited spatiotemporal or temporal specificity, and all modules exhibited their greatest spatiotemporal change during either W2 or W5 ( fig. S37) . A significant number of modules associated with adult-onset disorders were enriched for signatures of glial gene expression (P < 0.0266, hypergeometric test, table S12), and of particular interest were modules ME3 and ME7, which, in addition to glial signatures, were enriched for non-NUM sites, adult-active enhancers, sex-DEX genes, and AD-associated risk genes (Fig. 7A) .
Another module of interest was ME37, a module of 145 genes enriched for NUM sites and fetal enhancers and whose expression was enriched specifically in neurons as opposed to neural progenitors or glia. ME37 was also exceptional for its disease association, as it was enriched for genes associated with SCZ, IQ, and neuroticism but not for non-neurological characteristics such as height or a HBA1C-related trait (Fig. 7A) . Complementary module-based association analysis with Multi-marker Analysis of GenoMic Annotation (MAGMA), which tested for an enrichment in association to disease specifically around genes in any given module, confirmed enrichment for SCZ, IQ, and neuroticism in ME37 [MAGMA P values < 0.01; the false discovery rate (FDR) for all traits and modules was <0.3] (table S11). At the gene level, multiple genes in ME37 identified using our less stringent criteria for interaction were associated with up to four or more different traits and disorders, including MEF2C, ZNF184, TCF4, and SATB2, all genes critical for neurodevelopment and/or implicated in neurodevelopmental disorders (57) (58) (59) (60) (61) (62) (63) (64) (65) (Fig. 7, B and C). We also found that ME37 was specifically enriched in clusters of excitatory neurons in the fetal and adult NCX (Fig. 7D) , and further analysis of adult excitatory neuron populations identified in this study and an independent database of adult single nucleus data (27) suggested that this enrichment was selective for deep-layer neocortical neurons ( fig. S43) .
As the ASD GWAS resulted in only 13 significant genes, eight of which were non-protein coding, and because de novo germline mutations are known to contribute to ASD risk (66), we next developed two nonoverlapping lists of neurodevelopmental disorders (NDDs) [ASD, intellectual disability (ID), and developmental delay (DD)]. The first list was comprised of 65 high-confidence ASD risk genes (hcASD) associated with de novo mutations (66) . The second list included all ASD genes documented in the SFARI database (http://gene.sfari.org) under categories "syndromic" or with scores from 1 to 4, as well as an independent list of genes associated with DD (67), with genes overlapping the hcASD list removed. We found that these genes were also significantly enriched in ME37 (FDR < 0.0001, Fisher's exact test), and, commensurate with the cell-type enrichment found in ME37, the expression of genes in both of these lists was also enriched in several clusters of fetal and adult excitatory neurons identified in our single-cell dataset (Fig. 7D) . Medium spiny neurons in the STR, a population that has also been previously linked to ASD (68), were also enriched for the expression of ASD risk genes in the prenatal macaque (Fig. 7D) .
We finally studied the overlap between WGCNA modules and modules significantly enriched in differentially expressed genes in postmortem brains from patients of SCZ, BD, and ASD (69) . Interestingly, we found little overlap between modules enriched in genes exhibiting postmortem differences in expression between SCZ, BD, or ASD, as compared with neurotypical controls, and modules enriched in GWAS risk genes for these same disorders (P > 0.05, hypergeometric test) ( fig. S37 ). Emphasizing the necessity of studying neurotypical brain development, these observations may suggest a decoupling between the primary genetic causes of some neurological or psychiatric disorders and second-order effects manifesting as changes in gene expression months or years after disease onset.
Discussion
In this study, we have presented a comprehensive dataset and a multiplatform functional genomic analysis of the developing and adult human brain. The presence of these multiple data modalities in a unified resource, and largely from the same Although transcriptomic differences between distinct brain regions remain across time, they are developmentally specified and exhibit an overall cup-shaped pattern centered on a late fetal transition after a period of high intra-and interregional variation during embryonic and early or mid-fetal development. Multiple analyses of distinct transcriptomic features all confirm this transition begins well before birth. Our complementary transcriptomic study of the developing rhesus macaque brain (34) also revealed a similar global developmental pattern, with a first transition beginning before birth, indicating that this is a conserved feature of catarrhine primate neurodevelopment and not due to an artifact resulting from difficulties acquiring samples from late fetal and early postnatal development. Such a phenomenon is consistent with previously observed differences in transcriptomic and methylomic profiles of midfetal and postnatal human NCX (17) (18) (19) (20) and coincident with processes involved in regionspecific cell type generation, differentiation, and maturation (2). Crucially, this transition is notably distinct from previously reported phylogenetic hourglass-like patterns that occur during the embryonic organogenetic period in several invertebrate and vertebrate species (70, 71) . Moreover, the developmental (ontogenetic) cup-shaped pattern we observe coincides with an "evolutionary" (phylogenetic) cup-shaped pattern, in which developmental periods exhibiting high levels of interregional differences (for example, early to mid-fetal periods) also exhibit less conservation in gene expression patterns between human and macaque (34) .
Among the processes that become prominent during the late fetal period are astrogliogenesis, synaptogenesis, dendritogenesis, and neuronal activity. In contrast to a previous report of robust areal differences in the progression of synaptogenesis during the same time period in humans (36) , this and an accompanying study (34) found that genes associated with these processes exhibit largely synchronous expression trajectories across the developing NCX in both humans and macaque. However, myelination-which sharply increases during late fetal development, peaks after birth, and extends through childhood and adolescence (72)-is temporally asynchronous. This asynchronicity in oligodendrocyte development and myelination is not apparent at the level of oligodendrocyte progenitor cells (OPCs), which suggests that the maturation of OPCs into myelinating oligodendrocytes is a process with a variable onset and pace across areas. Similar observations were made in macaque (34) , indicating that this may be another conserved catarrhine feature.
Transcriptomic variation may reflect several distinct cellular and maturational reorganizational events. For example, as first described by Brodmann (73) , an ontogenetic six-layered Grundtypus foreshadows the adult NCX and transiently transforms the entirety of the neocortical plate beginning in the late fetal period, or in our W5. Furthermore, consistent with the extensive changes we observed in the cerebellar transcriptome during late fetal development and early postnatal ages, cerebellar granule cells, a cell type that represents about two-thirds of all neurons in the brain, are also generated predominately during this period (74) . The late fetal transition may therefore follow an inflection point after which developmental and spatiotemporal transcriptomic variations are transiently consolidated in advance of the emergence of cellular and functional differences between adult brain regions.
The mid-fetal period of high intra-and interregional divergence that immediately precedes the late fetal transition also coincides with a key developmental period previously associated with the etiology of ASD and SCZ (63, 65, 75) . Consequently, understanding the developmental and evolutionary history of this period may be essential for understanding neuropsychiatric disease. Integrating our multiple data modalities with gene coexpression modules allowed us to organize and characterize the whole-brain developmental transcriptome and identify modules with dynamic spatiotemporal trajectories, many of them showing a sharp late fetal transition, and enrichment in specific cell types, epigenetic activity, and disease-associated genes. Of particular interest is ME37, a module displaying the greatest rate of change in the NCX within the late fetal transition and in which putative risk genes for ASD, NDD, SCZ, IQ, and neuroticism converged. Several of the genes in ME37 were implicated by our study in multiple disorders and traits and have been linked previously to neurodevelopment and human disease. For example, MEF2C controls activity-dependent expression of neuronal genes, including those linked to synapse function and ASD (61, 63) , and Mef 2c-mutant mice display numerous behaviors reminiscent of ASD, ID, and SCZ (58) . Similarly, TCF4 regulates key neurodevelopmental processes, such as neurogenesis and synaptic plasticity, DNA methylation, and memory function processes (62, 64) . Moreover, mutations in both MEF2C and TCF4 result in intellectual disability in humans (57, 59, 60) . Numerous other genes in this module are similarly involved in neurodevelopment, have been implicated in human brain disease, and are highly plausible disease-risk genes and potentially therapeutic candidates. For example, NR4A2, a gene encoding another transcription factor in ME37 that we linked to neuroticism and IQ, has been linked to ASD and SCZ, among other disorders. Our study also links the gene for the transcription factor TSHZ3 to neuroticism and IQ, and previous efforts have linked murine Tshz3 to ASD and the fetal development of cortical excitatory projection neurons (76), a cell type and developmental period also implicated in ASD (63, 65) . Other genes in ME37, such as SATB2, FEZF2, SOX5, and TBR1, play critical roles in the development of cortical excitatory projection neurons and are mutated in NDDs (29-31, 65, 77, 78) . Similarly, the population of genes included in ME37, as well as genes linked to ASD and NDD, also exhibit regional and cell type-specific convergence in neocortical excitatory neurons. Moreover, the identification of ME37 and the overlap of genes in this module with those implicated in ASD and NDD illustrates how disease-association signals from common variants unveiled by GWAS for any given neuropsychiatric disorder can identify genes that have also been associated with the etiology of a different disease through the study of de novo mutations in patient populations (76) . Although not every gene in ME37 is likely to contribute to neuropsychiatric disease etiology, the coincident enrichment within this module of genes associated with multiple disorders or neurological traits, along with the multitude of genes in this module that are associated directly, suggests that neuropsychiatric disease might be considered through a broader lens encompassing additional aspects of brain dysfunction.
Interestingly, there is little overlap between the risk gene-associated modules we identified and modules enriched in genes that are differentially expressed in postmortem brains of SCZ, ASD, and BD, as compared to controls (69) . This comparison may help discriminate gene networks that are primary causes from those that are secondary or reactive in these neuropsychiatric disorders while emphasizing the importance of studying disease in the context of neurotypical development.
Taken together, these observations demonstrate the utility of this resource to perform integrated analysis for the understanding of brain development and function and for the rapid interpretation of findings from neuropsychiatric genomics.
Materials and methods summary
A full description of the materials and methods is available in the supplementary materials. Briefly, we precisely dissected multiple brain regions (HIP, STR, AMY, cerebellum, thalamus, and 11 neocortical areas) in more than 60 postmortem human brains ranging in age from 5 PCW to 64 PY. We then applied bulk tissue RNA-seq, scRNA-seq and snRNA-seq, smRNA-seq, DNA methylation assay, or ChIP-seq to generate multimodal datasets, often from the same brain. After applying stringent quality control checks and independent analysis of each dataset, we performed integrated analyses to gain insights into human brain development, function, and disease.
